APA (7th ed.) Citation

Oei, H. S., van der Meer, I. M., Hofman, A., Koudstaal, P. J., Stijnen, T., Breteler, M. M., & Witteman, J. C. (2005). Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study. Circulation (New York, N.Y.), 111(5), 570-575. https://doi.org/10.1161/01.CIR.0000154553.12214.CD

Chicago Style (17th ed.) Citation

Oei, Hok-Hay S., Irene M. van der Meer, Albert Hofman, Peter J. Koudstaal, Theo Stijnen, Monique M.B Breteler, and Jacqueline C.M Witteman. "Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study." Circulation (New York, N.Y.) 111, no. 5 (2005): 570-575. https://doi.org/10.1161/01.CIR.0000154553.12214.CD.

MLA (9th ed.) Citation

Oei, Hok-Hay S., et al. "Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study." Circulation (New York, N.Y.), vol. 111, no. 5, 2005, pp. 570-575, https://doi.org/10.1161/01.CIR.0000154553.12214.CD.